Drug Research

A new partnership with Thailand to share the expertise of genome sequencing, research collaboration, education and training opportunities, as well as genomics data handling will help UK patients. A MoU has been inked between deputy Prime Minister of Thailand, Anutin...

According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to stay strong despite ongoing concerns about the country's slow pace of drug authorizations. According to the analysis, the pharmaceutical business will remain competitive due to...

A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the inequalities in access by way of enhancing the affordability as well as availability of health products across low- and-middle-income countries (LMIC). The MPP which is...

The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE). Dupixent’s expanded authorisation in the European Union (EU) is intended to treat 12 years and older patients with EoE, who...

Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. that serves as one of the company’s global centers of excellence. The new facility will bring customers advanced capabilities for the discovery...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced mRNA-1345, an investigational mRNA vaccine candidate for respiratory syncytial virus (RSV), has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the...

Eli Lilly and Company announced plans to invest an additional $450 million and create at least 100 new jobs to expand its manufacturing capacity at the company's Research Triangle Park facility. The expansion includes additional parenteral filling, device assembly...